IN2014MN00139A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN00139A IN2014MN00139A IN139MUN2014A IN2014MN00139A IN 2014MN00139 A IN2014MN00139 A IN 2014MN00139A IN 139MUN2014 A IN139MUN2014 A IN 139MUN2014A IN 2014MN00139 A IN2014MN00139 A IN 2014MN00139A
- Authority
- IN
- India
- Prior art keywords
- endoxifen
- formulations
- diseases
- breast
- agents
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 4
- MHJBZVSGOZTKRH-IZHYLOQSSA-N 4-Hydroxy-N-desmethyltamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCNC)=CC=1)/C1=CC=C(O)C=C1 MHJBZVSGOZTKRH-IZHYLOQSSA-N 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 3
- 206010006187 Breast cancer Diseases 0.000 abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 210000000481 breast Anatomy 0.000 abstract 1
- 208000030270 breast disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86042006P | 2006-11-21 | 2006-11-21 | |
| US86078806P | 2006-11-22 | 2006-11-22 | |
| PCT/US2007/085443 WO2008070463A2 (en) | 2006-11-21 | 2007-11-21 | Endoxifen methods and compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00139A true IN2014MN00139A (enrdf_load_stackoverflow) | 2015-06-19 |
Family
ID=39492975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN139MUN2014 IN2014MN00139A (enrdf_load_stackoverflow) | 2006-11-21 | 2007-11-21 |
Country Status (11)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090291134A1 (en) * | 2006-11-21 | 2009-11-26 | Jina Pharmaceuticals, Inc. | Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases |
| IN2014MN00139A (enrdf_load_stackoverflow) | 2006-11-21 | 2015-06-19 | Jina Pharmaceuticals Inc | |
| EP2373305B1 (en) * | 2008-12-11 | 2017-03-15 | Besins Healthcare Luxembourg SARL | Transdermal pharmaceutical compositions comprising a serm |
| DK3228319T3 (da) | 2011-04-28 | 2020-09-07 | Oncopeptides Ab | Lyofiliseret præparat af cytotoksiske dipeptider |
| EP2668945A1 (de) | 2012-06-01 | 2013-12-04 | Bayer Technology Services GmbH | Genotyp- bzw. Phänotyp-basierte Arzeimittelformulierungen |
| MX365205B (es) * | 2012-10-26 | 2019-05-27 | Oncopeptides Ab | Preparaciones liofilizadas de melfalán flufenamida. |
| JP2018520182A (ja) * | 2015-07-14 | 2018-07-26 | アトッサ ジェネティックス インク． | 乳房障害を処置するための経乳頭方法及び組成物 |
| DE102015222031A1 (de) | 2015-11-10 | 2017-05-11 | Robert Bosch Gesellschaft Für Medizinische Forschung Mbh | Synthese von (Z)-Endoxifenhydrochlorid |
| US20170304232A1 (en) * | 2016-04-20 | 2017-10-26 | Northwestern University | Endoxifen For Local Transdermal Therapy To The Breast |
| CA3074302A1 (en) * | 2017-09-11 | 2019-03-14 | Atossa Therapeutics, Inc. | Topical compositions and methods for treatment |
| SG11202002105WA (en) | 2017-09-11 | 2020-04-29 | Atossa Therapeutics Inc | Methods for making and using endoxifen |
| AU2020300624A1 (en) * | 2019-07-03 | 2022-02-03 | Atossa Therapeutics, Inc. | Sustained release compositions of endoxifen |
| WO2021205404A1 (en) | 2020-04-10 | 2021-10-14 | Jina Pharmaceuticals, Inc. | Endoxifen for the treatment of bipolar i disorder |
| CN115484941A (zh) | 2020-04-10 | 2022-12-16 | 金纳药业公司 | 因多昔芬用于治疗双相i型障碍 |
| TW202302072A (zh) * | 2021-03-18 | 2023-01-16 | 國立臺灣大學 | 用於親水帶電化合物的脂質奈米顆粒遞送系統 |
| TW202340135A (zh) | 2022-01-12 | 2023-10-16 | 美商阿托薩醫療公司 | （ｚ）—因多昔芬之組合物及其富集方法 |
| CN119300811A (zh) * | 2022-04-26 | 2025-01-10 | 阿托萨治疗学公司 | 高剂量因多昔芬制剂和使用方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2817157A1 (de) * | 1978-04-17 | 1979-10-25 | Schering Ag | Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie |
| SK283026B6 (sk) * | 1994-08-04 | 2003-02-04 | Quadrant Holdings Cambridge Limited | Tuhý časticový prostriedok na terapeutické použitie a spôsob jeho prípravy |
| US6290991B1 (en) * | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| EP0935415B1 (en) * | 1996-05-01 | 2006-11-22 | Imarx Pharmaceutical Corp. | In vitro methods for delivering nucleic acids into a cell |
| US6090407A (en) * | 1997-09-23 | 2000-07-18 | Research Development Foundation | Small particle liposome aerosols for delivery of anti-cancer drugs |
| US7968532B2 (en) | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| ES2617747T3 (es) | 2006-10-10 | 2017-06-19 | Jina Pharmaceuticals Inc. | Sistemas acuosos para la preparación de compuestos farmacéuticos basados en lípidos; composiciones, procedimientos y usos de los mismos |
| WO2008048194A1 (en) | 2006-10-20 | 2008-04-24 | Yesilogluj Aysegul Yildiz | Use of the protein kinase c inhibitor tamoxifen for the treatment of bipolar disorder |
| JP2010509355A (ja) | 2006-11-06 | 2010-03-25 | ジャイナ ファーマシューティカルズ，インコーポレーテッド | グッグルリン脂質の方法および組成物 |
| US20090291134A1 (en) * | 2006-11-21 | 2009-11-26 | Jina Pharmaceuticals, Inc. | Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases |
| IN2014MN00139A (enrdf_load_stackoverflow) | 2006-11-21 | 2015-06-19 | Jina Pharmaceuticals Inc | |
| JP5720881B2 (ja) | 2011-01-31 | 2015-05-20 | 東芝ライテック株式会社 | Ｌｅｄランプ点灯装置および照明装置 |
-
2007
- 2007-11-21 IN IN139MUN2014 patent/IN2014MN00139A/en unknown
- 2007-11-21 ES ES07871563.8T patent/ES2665917T3/es active Active
- 2007-11-21 US US12/515,261 patent/US9333190B2/en active Active
- 2007-11-21 DK DK07871563.8T patent/DK2101731T3/en active
- 2007-11-21 JP JP2009538518A patent/JP2010510327A/ja active Pending
- 2007-11-21 WO PCT/US2007/085443 patent/WO2008070463A2/en active Application Filing
- 2007-11-21 PT PT78715638T patent/PT2101731T/pt unknown
- 2007-11-21 PL PL07871563T patent/PL2101731T3/pl unknown
- 2007-11-21 EP EP07871563.8A patent/EP2101731B1/en not_active Revoked
- 2007-11-21 CA CA2669913A patent/CA2669913C/en active Active
- 2007-11-21 HU HUE07871563A patent/HUE037109T2/hu unknown
-
2016
- 2016-04-27 US US15/139,687 patent/US10376479B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2101731A4 (en) | 2011-04-20 |
| EP2101731B1 (en) | 2018-01-31 |
| JP2010510327A (ja) | 2010-04-02 |
| US20100112041A1 (en) | 2010-05-06 |
| US10376479B2 (en) | 2019-08-13 |
| US9333190B2 (en) | 2016-05-10 |
| WO2008070463A2 (en) | 2008-06-12 |
| US20160346230A1 (en) | 2016-12-01 |
| PT2101731T (pt) | 2018-04-18 |
| HUE037109T2 (hu) | 2018-08-28 |
| DK2101731T3 (en) | 2018-04-16 |
| CA2669913A1 (en) | 2008-06-12 |
| WO2008070463A9 (en) | 2008-09-18 |
| EP2101731A2 (en) | 2009-09-23 |
| CA2669913C (en) | 2012-09-18 |
| WO2008070463A3 (en) | 2008-11-06 |
| ES2665917T3 (es) | 2018-04-30 |
| PL2101731T3 (pl) | 2018-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN00139A (enrdf_load_stackoverflow) | ||
| MY155649A (en) | Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease | |
| EA201690265A2 (ru) | Фармацевтические композиции, содержащие замещенные ациланилиды | |
| MX2010014233A (es) | Compuestos quimicos 251. | |
| UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
| MX350788B (es) | Compuestos de carbamato y preparación y uso de los mismos. | |
| TN2012000143A1 (en) | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof | |
| MX2008011978A (es) | Tratamiento del cancer de seno negativo al triple receptor. | |
| AU2011338389A8 (en) | Bicyclic compounds as Pim inhibitors | |
| MY198422A (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
| IL206563A (en) | A preparation or drug containing a suspension of blood cells that contain asparaginase for use in the treatment of pancreatic cancer | |
| TNSN07093A1 (en) | Bicyclic amides as kinase inhibitors | |
| MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
| UA86614C2 (ru) | Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата | |
| UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
| MY179527A (en) | Catecholamine derivatives useful for the treatment of parkinson's disease | |
| WO2007121088A3 (en) | Combinations of therapeutic agents for treating cancer | |
| GEP201606513B (en) | Pharmaceutical compositions for the treatment of cancer and other diseases or disorders | |
| GB0620385D0 (en) | Novel compounds | |
| EA201291089A1 (ru) | Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций | |
| PH12020500099A1 (en) | Therapeutic combination of a third generation egfr tyrosine kinase inhibitor and a cyclin d kinase inhibitor | |
| PH12020500096A1 (en) | Therapeutic combination of a third generation egfr tyrosine kinase inhibitor and a raf inhibitor | |
| TW200628473A (en) | Novel heterocycles | |
| EP2124554A4 (en) | COMPOSITIONS AND METHODS FOR CANCER TREATMENT | |
| TW201129361A (en) | Methods for treating pain |